Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    A EUFOREA comment on a lost comorbidity of asthma

    “Epidemiology of comorbidities and their association with asthma control” (Tomisa, G., Horváth, A., Sánta, B. et al. Epidemiology of comorbidities and their association with asthma control. Allergy Asthma Clin Im...

    Diego M. Conti, Peter W. Hellings, Zuzana Diamant in Allergy, Asthma & Clinical Immunology (2023)

  2. No Access

    Article

    CRS/CRSwNP in 2050: a look into the future

    Wytske Fokkens in Allergo Journal (2023)

  3. Article

    Open Access

    Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study

    Although the psychometric properties of patient-reported outcome measures (e.g. the 22-item Sino-nasal Outcomes Test [SNOT-22]) in chronic rhinosinusitis with nasal polyps (CRSwNP) have been defined, these def...

    Wytske Fokkens, Andrew Trigg, Stella E. Lee in Journal of Patient-Reported Outcomes (2023)

  4. Article

    Open Access

    Correction to: Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper

    An amendment to this paper has been published and can be accessed via the original article.

    Valerie Hox, Evelijn Lourijsen, Arnout Jordens in Clinical and Translational Allergy (2020)

  5. Article

    Open Access

    Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper

    Because of the inflammatory mechanisms of most chronic upper airway diseases such as rhinitis and chronic rhinosinusitis, systemic steroids have been used for their treatment for decades. However, it has been ...

    Valerie Hox, Evelijn Lourijsen, Arnout Jordens in Clinical and Translational Allergy (2020)

  6. Article

    Open Access

    Precision Medicine in Chronic Rhinosinusitis with Nasal Polyps

    Chronic rhinosinusitis is a disease with high prevalence, significant impact on health-related quality of life (HRQoL) and it is associated with substantial healthcare and productivity costs. We face an urgent...

    Klementina Avdeeva, Wytske Fokkens in Current Allergy and Asthma Reports (2018)

  7. No Access

    Chapter

    Chronic Rhinosinusitis with Polyposis: Diagnosis and Treatment

    When patients with chronic rhinosinusitis with polyposis (CRSwNP) visit our clinic, a proper diagnosis and evaluation of relevant factors is our first step in the patient care. CRSwNP is suspected in patients ...

    Wytske Fokkens in Rhinitis and Related Upper Respiratory Conditions (2018)

  8. Article

    Open Access

    European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases: report of the European Union Parliament Summit (29 March 2017)

    On March 29, 2017, a European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases (CRD) was organized by the European Forum for Research and Education in Allergy and Airway Diseases. ...

    Peter W. Hellings, David Borrelli, Sirpa Pietikainen in Clinical and Translational Allergy (2017)

  9. Article

    Open Access

    Capsaicin for Rhinitis

    Rhinitis is a multifactorial disease characterized by symptoms of sneezing, rhinorrhea, postnasal drip, and nasal congestion. Non-allergic rhinitis is characterized by rhinitis symptoms without systemic sensit...

    Wytske Fokkens, Peter Hellings, Christine Segboer in Current Allergy and Asthma Reports (2016)

  10. No Access

    Article

    IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs

    Transdifferentiation between group 1 and group 3 innate lymphoid cells (ILCs) has been observed in the gut. Spits and colleagues now show lung ILC2s are able to convert into ILC1s in an IL-12-dependent manner.

    Suzanne M Bal, Jochem H Bernink, Maho Nagasawa, Jelle Groot in Nature Immunology (2016)

  11. Article

    Open Access

    A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress

    The concept of control is gaining importance in the field of allergic rhinitis (AR), with a visual analogue scale (VAS) score being a validated, easy and attractive tool to evaluate AR symptom control. The doc...

    Peter W. Hellings, Antonella Muraro, Wytske Fokkens in Clinical and Translational Allergy (2015)

  12. No Access

    Article

    Complications of balloon packing in epistaxis

    Although balloon packing appears to be efficient to control epistaxis, severe local complications can occur. We describe four patients with local lesions after balloon packing. Prolonged balloon packing can ca...

    Lenka Vermeeren, Wynia Derks, Wytske Fokkens in European Archives of Oto-Rhino-Laryngology (2015)

  13. Article

    Open Access

    Rhinosinusitis in morbidity registrations in Dutch General Practice: a retro-spective case-control study

    There is only limited accurate data on the epidemiology of rhinosinusitis in primary care.

    Ruth Hoffmans, Tjard Schermer, Karin van der Linde, Hans Bor in BMC Family Practice (2015)

  14. Article

    Open Access

    A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch

    Wytske Fokkens, Peter Hellings, Joaquim Mullol in Clinical and Translational Allergy (2015)

  15. Article

    Open Access

    Ivacaftor and sinonasal pathology in a cystic fibrosis patient with genotype delta F508/S1215N

    Maaike Berkhout, Charlotte Vreede, Arwen Sprij in Clinical and Translational Allergy (2015)

  16. Article

    Open Access

    Breaking nasal epithelial cell tolerance lipopolysaccharide exposure by CD16 mediated co-stimulation with human serum immunoglobulin G

    Korneliusz Golebski, Danielle van Egmond in Clinical and Translational Allergy (2015)

  17. Article

    Open Access

    Acute and chronic rhinosinusitis and allergic rhinitis in relation to environment, comorbidity and ethnicity

    Ruth Hoffmans, Deniz Hastan, Kees van Drunen in Clinical and Translational Allergy (2015)

  18. Article

    Open Access

    Patient reported outcome measurements in chronic rhinosinusitis; assessing the correlation between RSOM-31 and VAS.

    Dirk Dietz de Loos, Lieke van der Meer in Clinical and Translational Allergy (2015)

  19. Article

    Open Access

    A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies

    Peter Hellings, Claus Bachert, Ralph Mösges in Clinical and Translational Allergy (2015)

  20. Article

    Open Access

    New insights into the pathogenesis of non-allergic rhinitis

    Christine Segboer, Wytske Fokkens, Kees Drunen van in Clinical and Translational Allergy (2015)

previous disabled Page of 2